Detalles de la búsqueda
1.
Epidemiology, characteristics of disease and unmet needs of patients with generalized pustular psoriasis: a large Italian Delphi consensus.
Dermatology
; 2024 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38493762
2.
Implementing well-being in the management of psoriasis: An expert recommendation.
J Eur Acad Dermatol Venereol
; 38(2): 302-310, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37822008
3.
Autoimmune Skin Diseases and Immune Checkpoint Inhibitors.
Crit Rev Immunol
; 42(3): 11-22, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-37017623
4.
The effect of the ketogenic diet on Acne: Could it be a therapeutic tool?
Crit Rev Food Sci Nutr
; : 1-20, 2023 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779329
5.
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference.
Dermatology
; 239(3): 387-392, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36754039
6.
Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and Effectiveness.
Dermatology
; 239(6): 868-876, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37311439
7.
Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate-to-severe plaque psoriasis patients in conditions close to clinical practice.
J Eur Acad Dermatol Venereol
; 37(10): 2004-2015, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246505
8.
Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS).
J Eur Acad Dermatol Venereol
; 37(5): 1017-1027, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695061
9.
Contact allergy to hydroxyisohexyl 3-cyclohexene carboxaldehyde in Italy: Prevalence, trend, and concordance with fragrance mix II.
Contact Dermatitis
; 88(2): 129-133, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305627
10.
Quality of life in patients with central centrifugal cicatricial alopecia: a preliminary study.
Br J Dermatol
; 187(5): 802-804, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35788915
11.
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients.
Br J Dermatol
; 187(6): 962-969, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35861701
12.
Very low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: an update for dermatologists and nutritionists.
Crit Rev Food Sci Nutr
; 62(2): 398-414, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-32969257
13.
Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: A retrospective analysis.
Dermatol Ther
; 35(12): e15933, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36227462
14.
Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective study.
Dermatol Ther
; 35(1): e15214, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34800070
15.
Reflectance confocal microscopy for Kaposi's sarcoma treatment monitoring after intralesional vincristine chemotherapy.
Dermatol Ther
; 35(7): e15539, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489056
16.
Urticaria relapse after mRNA COVID-19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single-center experience.
Dermatol Ther
; 35(11): e15838, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36109351
17.
Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication.
Dermatol Ther
; 35(12): e15901, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36200594
18.
Risankizumab treatment in psoriasis patients who failed anti-IL17: A 52-week real-life study.
Dermatol Ther
; 35(7): e15524, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35439341
19.
Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single-center retrospective study in a real-life setting.
Dermatol Ther
; 35(9): e15667, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35762107
20.
A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis.
Dermatol Ther
; 35(8): e15588, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35569129